Stock Research for BSTC

Current Price


Latest Update: 2018-03-16 16:00:00

$ 42.1500
$ 41.6900
$ 41.7400

Featured Broker: TradeStation

Get the due diligence for another stock.


BSTC Stock Chart & Research Data

The BSTC chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BSTC chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


BSTC Due diligence Resources & Stock Charts

The BSTC stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BSTC Detailed Price Forecast - CNN Money CNN View BSTC Detailed Summary - Google Finance
Yahoo View BSTC Detailed Summary - Yahoo! Finance Zacks View BSTC Stock Research & Analysis -

Stock Analysis

TradeIdeas View BSTC Trends & Analysis - Trade-Ideas Barrons View BSTC Major Holders - Barrons
NASDAQ View BSTC Call Transcripts - NASDAQ Seeking View BSTC Breaking News & Analysis - Seeking Alpha
Spotlight View BSTC Annual Report - OTC Report View BSTC OTC Short Report -
TradeKing View BSTC Fundamentals - TradeKing Charts View BSTC SEC Filings - Bar Chart
WSJ View Historical Prices for BSTC - The WSJ Morningstar View Performance/Total Return for BSTC - Morningstar
MarketWatch View the Analyst Estimates for BSTC - MarketWatch CNBC View the Earnings History for BSTC - CNBC
StockMarketWatch View the BSTC Earnings - StockMarketWatch MacroAxis View BSTC Buy or Sell Recommendations - MacroAxis
Bullish View the BSTC Bullish Patterns - American Bulls Short Pains View BSTC Short Pain Metrics -

Social Media Mentions

StockTwits View BSTC Stock Mentions - StockTwits PennyStocks View BSTC Stock Mentions - PennyStockTweets
Twitter View BSTC Stock Mentions - Twitter Invest Hub View BSTC Investment Forum News - Investor Hub
Yahoo View BSTC Stock Mentions - Yahoo! Message Board Seeking Alpha View BSTC Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for BSTC - Insider Cow View Insider Transactions for BSTC - Insider Cow
CNBC View BSTC Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BSTC - OTC Markets
Yahoo View Insider Transactions for BSTC - Yahoo! Finance NASDAQ View Institutional Holdings for BSTC - NASDAQ

Stock Charts

FinViz View BSTC Stock Insight & Charts - StockCharts View BSTC Investment Charts -
BarChart View BSTC Stock Overview & Charts - BarChart Trading View View BSTC User Generated Charts - Trading View

Latest Financial News for BSTC

New Research: Key Drivers of Growth for CNB Financial, Akebia Therapeutics, Mesoblast, 21Vianet Group, Old Line Bancshares, and BioSpecifics Technologies — Factors of Influence, Major Initiatives and Sustained Production
Posted on Friday March 16, 2018

NEW YORK, March 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...

BioSpecifics posts 4Q profit
Posted on Wednesday March 14, 2018

On a per-share basis, the Lynbrook, New York-based company said it had profit of 36 cents. Earnings, adjusted for pretax expenses, were 51 cents per share. The biopharmaceutical company posted revenue ...

BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2017 Financial Results
Posted on Wednesday March 14, 2018

LYNBROOK, N.Y. , March 14, 2018 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first ...

BioSpecifics Technologies Corp. Announces Presentation of Interim Data from Phase 1 Study of CCH for the Treatment of Uterine Fibroids at 65th Annual Scientific Meeting of the Society for Reproductive Investigation
Posted on Monday March 12, 2018

LYNBROOK, N.Y., March 12, 2018 /PRNewswire/ -- BioSpecifics Technologies Corp. (BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed as XIAFLEX® in the U.S. and Xiapex® in Europe, today announced the presentation of interim data from its ongoing Phase 1 trial of Collagenase Clostridium Histolyticum (CCH) for the treatment of uterine fibroids at the 65th Annual Scientific Meeting of the Society for Reproductive Investigation on Friday, March 9, 2018 in San Diego, CA. The data show the safety and effectiveness of the CCH injection method in five patients. "These interim data are very encouraging and show not only a significant reduction of collagen content but also the disruption of the tissue pattern in the uterine fibroids injected with CCH," said Thomas L. Wegman, President of BioSpecifics.

Warning: DOMDocument::load( failed to open stream: HTTP request failed! HTTP/1.0 404 Not Found in /home/allsites/ on line 494

Warning: DOMDocument::load(): I/O warning : failed to load external entity "" in /home/allsites/ on line 494

Enter a stock symbol to view the stock details.